Acute anterior uveitis following intravitreal injection of bevacizumab

Ophthalmic Surgery Lasers and Imaging

Volumn 44, Issue 1, 2013, Pages 25-27

  Mozayan, Arash ^a   Farah, Samer ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; GATIFLOXACIN; POVIDONE IODINE; PREDNISOLONE; PROXYMETACAINE; RANIBIZUMAB; CORTICOSTEROID; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ACUTE ANTERIOR UVEITIS; AGED; ARTICLE; CORTICOSTEROID THERAPY; DIABETIC RETINOPATHY; DRUG RESPONSE; EYE PAIN; FEMALE; HUMAN; HYPOPYON; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PHOTOPHOBIA; PHYSICIAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; TOPICAL TREATMENT; UVEITIS; VISUAL ACUITY; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG SAFETY; INJECTION SITE REACTION; IRIDOCYCLITIS; MALE; REVIEW; TREATMENT OUTCOME; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CONJUNCTIVITIS; DRUG ANTAGONISM; INCIDENCE; INTRAVITREAL DRUG ADMINISTRATION; IRITIS; RETINA DISEASE; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CONJUNCTIVITIS; EYE PAIN; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; IRITIS; PHOTOPHOBIA; RETINAL DISEASES; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

MLCS; MLOWN;

EID: 84872736201     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/23258160-20121221-08     Document Type: Article

References (18)

1. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363-372.
2. Spaide R F, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006;26:383-390.
3. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419-425.
4. Iturralde D, Spaide R F, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central vein occlusion: A short-term study. Retina. 2006;26:279-284.
5. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695.
6. CATT Research Group, Martin D F, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897-1908.
7. Wickremasinghe SS, Michalova K, Gilhotra J, et al. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology. 2008;115:1911-1915.
8. Pieramici DJ, Avery RL, Castellarin AA, Nasir MA, Rabena M. Case of anterior uveitis after intravitreal injection of bevacizumab. Retina. 2006;26:841-842.
9. Jonas JB, Spandau UH, Rensch F, Von Baltz S, Schlichtenbrede F. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocul Pharmacol Ther. 2007;23:240-242.
10. Shima C, Sakaguchi H, Gomi F, et al. Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol. 2008;86:372-376.
11. Bakri SJ, Larson TA, Edwards AO. Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2008;246:779-781.
12. Sato T, Emi K, Ikeda T, et al. Severe intraocular inflammation after intravitreal injection of bevacizumab. Ophthalmology. 2010;117:512-516.
13. Mamalis N, Edelhauser H F, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32:324-333.
14. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol. 2005;140:509-516.
15. Ho J, Loewenstein JI. Endophthalmitis associated with intravitreal injections. Int Ophthalmol Clin. 2007;47:199-208.
16. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008;28:1395-1399.
17. Johnson D, Hollands H, Hollands S, Sharma S. Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol. 2010;45:239-242.
18. Bakri SJ, Snyder MR, Reid JM, Pullido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007;114:855-859.